# Tetrandrine Tablets Used in the Treatment of COVID-19

> **NCT04308317** · PHASE4 · UNKNOWN · sponsor: **Henan Provincial People's Hospital** · enrollment: 60 (estimated)

## Conditions studied

- Corona Virus Disease 2019,COVID-19

## Interventions

- **DRUG:** Tetrandrine

## Key facts

- **NCT ID:** NCT04308317
- **Lead sponsor:** Henan Provincial People's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-03-05
- **Primary completion:** 2021-03-01
- **Final completion:** 2021-05-01
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2020-03-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04308317

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04308317, "Tetrandrine Tablets Used in the Treatment of COVID-19". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04308317. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*